Lanean...
Ticagrelor-Induced Prolongation of the QTc Interval
BACKGROUND: Ticagrelor has been accepted as a class I antiplatelet agent in patients undergoing percutaneous coronary angioplasty (PTCA). There have been cases reported on ticagrelor being associated with various cardiac conduction defects. But there is no evidence of QTc prolongation associated wit...
Gorde:
| Argitaratua izan da: | Case Rep Cardiol |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Hindawi
2019
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6881594/ https://ncbi.nlm.nih.gov/pubmed/31827937 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5984847 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|